Adapting to the Evolving Era of Oncology: Implications and Strategies for Research Institutions
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
REVIEWS Frequently Asked Questions Find answers to our most frequently asked ethical review questions here. Can’t find what you need?
Simplify federal grant submissions with Advarra’s expert IRB support, offering compliance guidance and oversight for both single and multisite studies.
Advarra reviews research in the U.S., Puerto Rico, Canada, and limited minimal risk research outside these regions.
Advarra’s Institutional Review Board (IRB) offers expert guidance, supporting more than 3,500 institutions, academic medical centers, and site networks.
Leverage Advarra’s expertise in Canada as the only officially recognized IRB/REB, offering extensive site reach and top-notch research ethics services.
As the research community’s preferred sIRB partner, we help you meet regulatory requirements with efficiency and transparency.
Achieving diversity, equity, and inclusion (DEI) in clinical trials is crucial for producing comprehensive and effective medical research benefitting all
Join this webinar to learn about FDA insights on DCTs and biologics. Dr. Eisenman discusses biosafety, risks, and key considerations for safe trials.
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
At institutional research programs around the U.S., there exists a pervasive myth: internal institutional review board (IRB) reviews are free.
Artificial intelligence (AI) has taken the world by storm – and regulators are paying attention. The European Parliament recently adopted